Jul 31, 2024 / 10:30AM GMT
Presentation
Jul 31, 2024 / 10:30AM GMT
=====================
Corporate Participants
=====================
* Christopher David O'Reilly
Takeda Pharmaceutical Co Ltd - Head of Investor Relations
* Christophe Weber
Takeda Pharmaceutical Co Ltd - President, Chief Executive Officer, Representative Director
* Milano Furuta
Takeda Pharmaceutical Co Ltd - Chief Financial Officer, Director
* Andrew Plump
Takeda Pharmaceutical Co Ltd - President of Research & Development, Vice President of Subsidiary, Director
* Julie Kim
Takeda Pharmaceutical Co Ltd - President of US Business Unit
=====================
Conference Call Participants
=====================
* Hiroyuki Matsubara
Nomura Securities Co., Ltd. - Analyst
* Steve Barker
Jefferies Group (Trades,
Takeda Pharmaceutical Co Ltd
(FRA:TKD)
€
25.61
0.16 (0.63%)
Market Cap: 40.44 Bil
Enterprise Value: 65.50 Bil
PE Ratio: 23.27
PB Ratio: 0.97
GF Score: 82/100 Q1 2025 Takeda Pharmaceutical Co Ltd Earnings Presentation Transcript
Jul 31, 2024 / 10:30AM GMT
Release Date Price:
€25.21
(-0.20%)
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot